Company Filing History:
1 out of 119 
1 out of 26 
1 out of 2 Years Active: 2025
Title: The Innovative Contributions of Dong Wang
Introduction
Dong Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemophagocytic syndrome. His work exemplifies the intersection of innovation and healthcare, showcasing the potential of chemical compounds in medical applications.
Latest Patents
Dong Wang holds a patent for the "Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome." This invention relates to the use of a pyrrolopyrimidine compound, specifically a compound of formula (I), its stereoisomers, or pharmaceutically acceptable salts, in the treatment of this serious medical condition. The patent highlights the importance of this compound in developing effective therapies for patients suffering from hemophagocytic syndrome.
Career Highlights
Throughout his career, Dong Wang has worked with prominent pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to various projects aimed at advancing medical treatments and improving patient outcomes.
Collaborations
Dong Wang has collaborated with esteemed colleagues in his field, including Hongming Liang and Xiquan Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical research.
Conclusion
Dong Wang's contributions to the field of pharmaceuticals, particularly through his patent on pyrrolopyrimidine compounds, demonstrate his commitment to improving healthcare solutions. His work continues to inspire future innovations in medical treatments.